104 related articles for article (PubMed ID: 2214197)
41. Fine needle aspiration biopsy and molecular analysis in differential diagnosis of lymphoproliferative diseases of the orbit and eye adnexa.
Wolska-Szmidt E; Jakubowska A; Krzystolik K; Chosia M
Pol J Pathol; 2004; 55(2):51-7. PubMed ID: 15469207
[TBL] [Abstract][Full Text] [Related]
42. [Immunologic study of lymphoproliferative diseases].
Cabrera ME; Majlis A; Labra S; Carrasco AM
Rev Med Chil; 1992 Jul; 120(7):772-7. PubMed ID: 1341818
[TBL] [Abstract][Full Text] [Related]
43. Merkel cell carcinoma with a follicular lymphocytic infiltrate: report of 2 cases.
Vazmitel M; Michal M; Kempf W; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2008 Aug; 30(4):389-91. PubMed ID: 18645313
[TBL] [Abstract][Full Text] [Related]
44. Hairy cell leukemia and other "hairy-cell" lymphoproliferative disorders (LPD-HC): the significance of morphologic, histologic and immunologic studies.
Yavorkovsky LL; Gipsh NM; Karminskaya NM; Udris OYu ; Nikulshin SV; Yavorkovsky LI
Neoplasma; 1990; 37(4):439-44. PubMed ID: 2234204
[TBL] [Abstract][Full Text] [Related]
45. [Lymphoproliferative lung lesions (pseudolymphoma--malignant lymphoma].
Brittig F; Kecskés L; Pócza K
Orv Hetil; 1989 Feb; 130(7):341-2, 345-7. PubMed ID: 2493145
[TBL] [Abstract][Full Text] [Related]
46. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
47. [Lymphangioleiomyomatosis. Problems in differential diagnosis, etiology and prognosis (author's transl)].
Koch HK; Bertram E; Lesch R
Radiologe; 1980 Oct; 20(10):500-4. PubMed ID: 7444043
[TBL] [Abstract][Full Text] [Related]
48. [Double-marker (T + B) lymphocytes in lymphoproliferative diseases].
Pecze K; Dalmi L; Rák K
Orv Hetil; 1982 Jun; 123(26):1595-7. PubMed ID: 6981087
[No Abstract] [Full Text] [Related]
49. [Clinical and follow-up study of 40 cases of asymptomatic monoclonal gammopathy].
Herráez García J; Sánchez Fuentes D; Zurdo García JR; Criado Jiménez M; Sánchez Rodríguez A
Rev Clin Esp; 1987 Apr; 180(6):300-3. PubMed ID: 3602536
[No Abstract] [Full Text] [Related]
50. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
Kojima M; Motoori T; Asano S; Nakamura S
Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
[TBL] [Abstract][Full Text] [Related]
51. [Serum and surface immunoglobulin studies in the diagnosis of lymphoproliferative diseases].
Kharchenko MF; Moiseeva VP; Khodzhakulieva AM; Gal'perina IIu; Rybakova LP
Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):7-11. PubMed ID: 7301792
[No Abstract] [Full Text] [Related]
52. [Immunologic and cytochemical characteristics of the cellular substrate in lymphoproliferative diseases].
Soboleva TN
Lab Delo; 1983; (8):3-7. PubMed ID: 6195403
[No Abstract] [Full Text] [Related]
53. Chronic lymphoproliferative disease of large granular lymphocytes.
Vahancík A; Babusíková O; Ujházy P; Klobusická M; Jakubovský J; Izakovic V
Neoplasma; 1988; 35(1):81-9. PubMed ID: 3352841
[TBL] [Abstract][Full Text] [Related]
54. A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation.
Hourigan MJ; Doecke J; Mollee PN; Gill DS; Norris D; Johnson DW; Gandhi MK
Br J Haematol; 2008 Jun; 141(6):904-7. PubMed ID: 18422782
[No Abstract] [Full Text] [Related]
55. [Chronic lymphoproliferative disorders].
Salles G
Rev Prat; 2002 May; 52(9):966-71. PubMed ID: 12063762
[TBL] [Abstract][Full Text] [Related]
56. A fatal lymphoproliferative disorder primarily involving the lungs of a child.
Kadivar M; Mahjoub F; Ahmadi M; Izadyar M; Tirgari F; Tebbi Koodakan M
Med Pediatr Oncol; 2001 Mar; 36(3):404-6. PubMed ID: 11241449
[No Abstract] [Full Text] [Related]
57. [The study of intracellular immunoglobulins by the immunoperoxidase method in lymphoproliferative diseases].
Soboleva TN; Lugovskaia SA; Morozova VT; Lukina EA; Mokeeva RA
Gematol Transfuziol; 1986 Aug; 31(8):27-33. PubMed ID: 3530874
[No Abstract] [Full Text] [Related]
58. Oral manifestation of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: A potential diagnostic pitfall.
Saggini A; Baciorri F; Di Prete M; Zizzari AG; Anemona L
J Cutan Pathol; 2020 May; 47(5):494-496. PubMed ID: 32003865
[No Abstract] [Full Text] [Related]
59. [The hydrocortisone test (400 mg hydrocortisone test) for the study of the "recirculating" lymphocyte population. Tests of patients with lymphoproliferative diseases and solid neoplasms].
Loni C; Bertoncini GF; Tortelli G; Lolli G; Bianchini A; Paolini E; Tolaini P
Quad Sclavo Diagn; 1981 Mar; 17(1):1-9. PubMed ID: 7031750
[TBL] [Abstract][Full Text] [Related]
60. The atypical lymphoproliferative disorders: tissue expression.
Beltrami CA
Clin Exp Rheumatol; 1996; 14 Suppl 14():S15-9. PubMed ID: 8722195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
